Ads
related to: the income statement is also known as the statement of financial position
Search results
Earnings call: Duckhorn navigates market challenges, posts growth By Investing.com
Investing.com· 2 days agoDuckhorn Portfolio (NYSE: NAPA) has reported its financial results for the third quarter ended April...
Tori Spelling owes more than $200,000 on a bank loan — here’s what you can learn from her money...
Moneywise via Yahoo Finance· 3 days agoShe didn’t want to be known as “the rich little girl.” Spelling eventually gave in to her family...
Earnings call: Carlyle Credit maintains dividend, sees robust CLO market activity
Investing.com· 6 days agoThe strong performance of its diversified CLO portfolio and solid financial results, including a...
Earnings call: Five Below revealed a 12% increase in total sales By Investing.com
Investing.com· 2 days agoThe discount retailer attributed the decline in comparable sales to fewer transactions as customers...
How to Vet the Financials of a Continuing-Care Retirement Community
The Wall Street Journal· 2 days agoDue diligence can be difficult thanks to the communities’ complex business models, but prospective...
Ocuphire Pharma to present APX3330 clinical updates By Investing.com
Investing.com· 2 days agoOcuphire Pharma, Inc. (NASDAQ:OCUP), a biopharmaceutical company, is set to present clinical updates...
Q1 2025 Sprinklr Inc Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 3 days agoManish will provide more details in his remarks. As...Our new leadership and an industry-leading AI-powered platform position us well for long-term growth and success. Sprinklr ...
Earnings call: Limoneira's Q2 sees EBITDA double, shifts focus to avocados By Investing.com
Investing.com· 2 days agoThe company's strategic shift towards expanding avocado production is evident as they plan to plant...
Can-Fite's Namodenoson gains FDA Fast Track for liver cancer By Investing.com
Investing.com· 4 days agoFood and Drug Administration (FDA) for the treatment of advanced liver cancer, also known as...
I-Mab and Bristol Myers team up for cancer drug trial By Investing.com
Investing.com· 3 days agoI-Mab (NASDAQ: IMAB), a biotechnology firm specializing in cancer immunotherapies, has announced a...
